ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor

February 21, 2003

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995

In Brief: Nutrition Research Intrigues Investigators After All; Advisory Committee Being Formed

March 7, 1975